Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""ANTITUBERCULAR agents"" wg kryterium: Temat


Tytuł:
The clinical profile and outcomes of drug resistant tuberculosis in Central Province of Zambia.
Autorzy:
Chanda E; Department of Public Health, Texila American University, Lusaka, Zambia. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Apr 01; Vol. 24 (1), pp. 364. Date of Electronic Publication: 2024 Apr 01.
Typ publikacji:
Review; Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Adult ; Humans ; Male ; Middle Aged ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Cross-Sectional Studies ; Prevalence ; Recurrence ; Retrospective Studies ; Zambia/epidemiology ; Female
Czasopismo naukowe
Tytuł:
The exceptions that prove the rule-a historical view of bedaquiline susceptibility.
Autorzy:
Miotto P; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Cirillo DM; Emerging Bacterial Pathogens Unit, IRCCS San Raffaele Scientific Institute, Milan, Italy.
Schön T; Department of Infectious Diseases, Region Östergötland, Linköping University Hospital, Linköping, Sweden.; Division of Infection and Inflammation, Institute of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden.; Department of Infectious Diseases, Kalmar County Hospital, Linköping University, Kalmar, Sweden.
Köser CU; Department of Genetics, University of Cambridge, Cambridge, UK. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Mar 13; Vol. 16 (1), pp. 39. Date of Electronic Publication: 2024 Mar 13.
Typ publikacji:
Journal Article
MeSH Terms:
Diarylquinolines*/pharmacology
Mycobacterium tuberculosis*/genetics
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Mutation
Czasopismo naukowe
Tytuł:
Detection of a historic reservoir of bedaquiline/clofazimine resistance-associated variants in Mycobacterium tuberculosis.
Autorzy:
Nimmo C; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .; Division of Infection and Immunity, University College London, London, UK. .; Africa Health Research Institute, Durban, South Africa. .
Ortiz AT; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.; Department of Medicine, Imperial College, London, UK.
Tan CCS; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.
Pang J; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.; Division of Infection and Immunity, University College London, London, UK.
Acman M; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK.
Millard J; Africa Health Research Institute, Durban, South Africa.; Wellcome Trust Liverpool Glasgow Centre for Global Health Research, Liverpool, UK.; Institute of Infection and Global Health, University of Liverpool, Liverpool, UK.
Padayatchi N; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.
Grant AD; Africa Health Research Institute, Durban, South Africa.; TB Centre, London School of Hygiene & Tropical Medicine, London, UK.
O'Donnell M; CAPRISA MRC-HIV-TB Pathogenesis and Treatment Research Unit, Durban, South Africa.; Department of Medicine & Epidemiology, Columbia University Irving Medical Center, New York, NY, USA.
Pym A; Africa Health Research Institute, Durban, South Africa.
Brynildsrud OB; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Eldholm V; Division of Infectious Diseases and Environmental Health, Norwegian Institute of Public Health, Oslo, Norway.
Grandjean L; Division of Infection and Immunity, University College London, London, UK.; Laboratorio de Investigacion y Enfermedades Infecciosas, Universidad Peruana Cayetano Heredia, Lima, Peru.; Department of Infection, Immunity and Inflammation, Institute of Child Health, University College London, London, UK.
Didelot X; School of Life Sciences and Department of Statistics, University of Warwick, Coventry, UK.
Balloux F; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .
van Dorp L; UCL Genetics Institute, University College London, Darwin Building, Gower Street, London, UK. .
Pokaż więcej
Źródło:
Genome medicine [Genome Med] 2024 Feb 19; Vol. 16 (1), pp. 34. Date of Electronic Publication: 2024 Feb 19.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Tuberculosis*/drug therapy
Diarylquinolines*
Humans ; Clofazimine ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Microbial Sensitivity Tests ; Phylogeny
Czasopismo naukowe
Tytuł:
Determinants of drug-resistant tuberculosis in Hunan province, China: a case-control study.
Autorzy:
Akalu TY; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia. .; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia. .; Institute of Public Health, College of Medicine and Health Sciences, University of Gondar, Gondar, Ethiopia. .
Clements ACA; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia.; Penninsula Medical School, University of Plymouth, Plymouth, UK.
Xu Z; Xiangya School of Public Health, Central South University, Changsha, China.
Bai L; TB Control Institute of Hunan Province, Changsha, China.
Alene KA; School of Population Health, Faculty of Health Sciences, Curtin University, Perth, Western Australia, Australia.; Geospatial and Tuberculosis Research Team, Telethon Kids Institute, Perth, Western Australia, Australia.
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 13; Vol. 24 (1), pp. 198. Date of Electronic Publication: 2024 Feb 13.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Multidrug-Resistant*/complications
Humans ; Adult ; Adolescent ; Young Adult ; Middle Aged ; Case-Control Studies ; Microbial Sensitivity Tests ; China/epidemiology ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use
Czasopismo naukowe
Tytuł:
TB-DROP: deep learning-based drug resistance prediction of Mycobacterium tuberculosis utilizing whole genome mutations.
Autorzy:
Wang Y; Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Jiang Z; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Liang P; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.; Zhejiang Yangshengtang Institute of Natural Medication Co., Ltd, Hangzhou, China.
Liu Z; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China.
Cai H; Center of Growth, Metabolism and Aging, Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China. .
Sun Q; Key Laboratory of Bio-Resources and Eco-Environment of the Ministry of Education, College of Life Sciences, Sichuan University, Chengdu, 610064, China. .
Pokaż więcej
Źródło:
BMC genomics [BMC Genomics] 2024 Feb 12; Vol. 25 (1), pp. 167. Date of Electronic Publication: 2024 Feb 12.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Deep Learning*
Tuberculosis*/microbiology
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Mutation ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł:
Metabolites from Streptomyces aureus (VTCC43181) and Their Inhibition of Mycobacterium tuberculosis ClpC1 Protein.
Autorzy:
Tran TTP; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Huynh NNT; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Natural Sciences, Phu Yen University, 01 Nguyen Van Huyen Road, Tuy Hoa City 56000, Vietnam.
Pham NT; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen DT; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Tran CV; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen UQ; Institute of Microbiology and Biotechnology, Vietnam National University Hanoi, 44, Xuan Thuy Road, Cau Giay, Hanoi 10000, Vietnam.
Ho AN; Institute of Biotechnology, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Suh JW; Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Republic of Korea.
Cheng J; Center for Nutraceutical and Pharmaceutical Materials, Myongji University, Yongin 17058, Republic of Korea.
Nguyen TKN; Faculty of Biology, University of Natural Sciences, Vietnam National University, Hanoi, 334 Nguyen Trai Road, Thanh Xuân, Hanoi 10000, Vietnam.
Tran SV; Institute of Chemistry, Vietnam Academy of Science and Technology (VAST),18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.; Faculty of Chemistry, Graduate University of Science and Technology, VAST, 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Nguyen DM; Institute of Genome Research, Vietnam Academy of Science and Technology (VAST), 18 Hoang Quoc Viet Road, Cau Giay, Hanoi 10000, Vietnam.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Feb 04; Vol. 29 (3). Date of Electronic Publication: 2024 Feb 04.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Streptomyces*
Staphylococcus aureus/metabolism ; Antitubercular Agents/pharmacology ; Antitubercular Agents/metabolism ; Bacterial Proteins/chemistry ; Adenosine Triphosphatases/metabolism
SCR Organism:
Streptomyces aureus
Czasopismo naukowe
Tytuł:
Identification of Novel Antimicrobial Compounds Targeting Mycobacterium tuberculosis S -Adenosyl-L-Homocysteine Hydrolase Using Dual Hierarchical In Silico Structure-Based Drug Screening.
Autorzy:
Ito H; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Monobe K; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Okubo S; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Aoki S; Department of Bioscience and Bioinformatics, Graduate School of Computer Science and Systems Engineering, Kyushu Institute of Technology, Iizuka 820-8502, Japan.
Pokaż więcej
Źródło:
Molecules (Basel, Switzerland) [Molecules] 2024 Mar 14; Vol. 29 (6). Date of Electronic Publication: 2024 Mar 14.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis*/microbiology
Humans ; Antitubercular Agents/chemistry ; Drug Evaluation, Preclinical ; Homocysteine/pharmacology ; Hydrolases/pharmacology ; Molecular Docking Simulation
Czasopismo naukowe
Tytuł:
Multi-platform whole genome sequencing for tuberculosis clinical and surveillance applications.
Autorzy:
Thorpe J; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Sawaengdee W; Department of Medical Sciences, Medical Genetics Center, Medical Life Sciences Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand.
Ward D; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Campos M; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Wichukchinda N; Department of Medical Sciences, Medical Genetics Center, Medical Life Sciences Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand.
Chaiyasirinroje B; TB/HIV Research Foundation (THRF), Chiang Rai, 57000, Thailand.
Thanraka A; Department of Medical Technology, Chiangrai Prachanukroh Hospital, Chiang Rai, 57000, Thailand.
Chumpol J; The Office of Disease Prevention and Control 7, Khon Kaen, 40000, Thailand.
Phelan JE; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Campino S; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK.
Mahasirimongkol S; Department of Medical Sciences, Medical Genetics Center, Medical Life Sciences Institute, Ministry of Public Health, Nonthaburi, 11000, Thailand.
Clark TG; Department of Infection Biology, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. .; Faculty of Epidemiology and Population Health, London School of Hygiene and Tropical Medicine, London, WC1E 7HT, UK. .
Pokaż więcej
Źródło:
Scientific reports [Sci Rep] 2024 Mar 03; Vol. 14 (1), pp. 5201. Date of Electronic Publication: 2024 Mar 03.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/microbiology
Tuberculosis*/drug therapy
Mycobacterium tuberculosis*
Humans ; Antitubercular Agents/pharmacology ; Drug Resistance, Multiple, Bacterial/genetics ; Phylogeny ; Whole Genome Sequencing/methods ; Microbial Sensitivity Tests
Czasopismo naukowe
Tytuł:
Power to identify exposure-response relationships in phase IIa pulmonary tuberculosis trials with multi-dimensional bacterial load modeling.
Autorzy:
Koele SE; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.
Dorlo TPC; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Upton CM; TASK Applied Science, Cape Town, South Africa.
Aarnoutse RE; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.
Svensson EM; Department of Pharmacy, Radboudumc Research Institute for Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, The Netherlands.; Department of Pharmacy, Uppsala University, Uppsala, Sweden.
Pokaż więcej
Źródło:
CPT: pharmacometrics & systems pharmacology [CPT Pharmacometrics Syst Pharmacol] 2024 Mar; Vol. 13 (3), pp. 374-385. Date of Electronic Publication: 2023 Dec 15.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Pulmonary*/drug therapy
Humans ; Antitubercular Agents/pharmacology ; Bacterial Load ; Microbial Sensitivity Tests ; Clinical Trials, Phase II as Topic
Czasopismo naukowe
Tytuł:
Novel mutation in efflux pump Rv1258c (Tap) gene in drug resistant clinical isolates of Mycobacterium tuberculosis in Iran.
Autorzy:
Farzaneh S; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Norouzi F; Department of Microbiology, School of Medicine, Fasa University of Medical Sciences, Fasa, Iran.
Fazeli H; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Salehi M; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Safari M; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Nasr Esfahani B; Department of Microbiology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran.
Pokaż więcej
Źródło:
Journal of infection in developing countries [J Infect Dev Ctries] 2024 Feb 29; Vol. 18 (2), pp. 243-250. Date of Electronic Publication: 2024 Feb 29.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*/genetics
Tuberculosis, Multidrug-Resistant*
Humans ; Antitubercular Agents/pharmacology ; Iran ; Mutation ; Microbial Sensitivity Tests ; Bacterial Proteins/genetics
Czasopismo naukowe
Tytuł:
Benzothiadiazinone-1,1-Dioxide Carbonic Anhydrase Inhibitors Suppress the Growth of Drug-Resistant Mycobacterium tuberculosis Strains.
Autorzy:
Bua S; Research Institute of the University of Bucharest (ICUB), University of Bucharest, 050095 Bucharest, Romania.
Bonardi A; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Mük GR; Faculty of Biology, University of Bucharest, Splaiul Independenței 91-95, 050095 Bucharest, Romania.; St. Stephen's Pneumoftiziology Hospital, Șoseaua Ștefan cel Mare 11, 020122 Bucharest, Romania.
Nocentini A; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Gratteri P; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Supuran CT; Pharmaceutical and Nutraceutical Section, Laboratory of Molecular Modeling Cheminformatics & QSA, Neurofarba Department, University of Florence, Via U. Schiff 6, Sesto Fiorentino, 50019 Florence, Italy.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Feb 23; Vol. 25 (5). Date of Electronic Publication: 2024 Feb 23.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Carbonic Anhydrases*/metabolism
Tuberculosis*
Humans ; Molecular Structure ; Carbonic Anhydrase Inhibitors/pharmacology ; Isoenzymes/metabolism ; Structure-Activity Relationship ; Antitubercular Agents/pharmacology ; Carbonic Anhydrase IX
Czasopismo naukowe
Tytuł:
On the onset and dispersal of a major MDR TB clone among HIV-negative patients, Tunisia.
Autorzy:
Dekhil N; Unit of Typing and Genetics of Mycobacteria, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development, Pasteur Institute, Tunis, University of Tunis El Manar, Tunis, Tunisia. .
Mardassi H; Unit of Typing and Genetics of Mycobacteria, Laboratory of Molecular Microbiology, Vaccinology, and Biotechnology Development, Pasteur Institute, Tunis, University of Tunis El Manar, Tunis, Tunisia. .
Pokaż więcej
Źródło:
Antimicrobial resistance and infection control [Antimicrob Resist Infect Control] 2024 Feb 14; Vol. 13 (1), pp. 18. Date of Electronic Publication: 2024 Feb 14.
Typ publikacji:
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Mycobacterium tuberculosis*/genetics
HIV Infections*/epidemiology
HIV Infections*/drug therapy
Humans ; Antitubercular Agents/therapeutic use ; Tunisia/epidemiology
Czasopismo naukowe
Tytuł:
Time to sputum culture conversion and its associated factors among drug-resistant tuberculosis patients: a systematic review and meta-analysis.
Autorzy:
Wenlu Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Xia Z; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Chuntao W; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Qiaolin Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Xujue X; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Rong Y; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China.
Dan S; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Xi Y; Chengdu University of Traditional Chinese Medicine, Chengdu, Sichuan, China.
Bin W; Nursing Department, Public Health Clinical Center of Chengdu, Chengdu, Sichuan, China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Feb 07; Vol. 24 (1), pp. 169. Date of Electronic Publication: 2024 Feb 07.
Typ publikacji:
Meta-Analysis; Systematic Review; Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Pulmonary*/diagnosis
Tuberculosis, Pulmonary*/drug therapy
Mycobacterium tuberculosis*
Humans ; Female ; Antitubercular Agents/therapeutic use ; Sputum ; Risk Factors ; Treatment Outcome
Czasopismo naukowe
Tytuł:
A precision overview of genomic resistance screening in Ecuadorian isolates of Mycobacterium tuberculosis using web-based bioinformatics tools.
Autorzy:
Morey-León G; Facultad de Ciencias de la Salud, Universidad Espíritu Santo, Samborondón, Ecuador.; Universidad de la República, Montevideo, Uruguay.; University of Guayaquil, Guayaquil, Ecuador.
Mejía-Ponce PM; Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Monterrey, Nuevo León, México.
Granda Pardo JC; Centro de Referencia Nacional de Micobacterias, Instituto Nacional de Investigación en Salud Pública Dr Leopoldo Izquieta Perez, INSPI-LIP, Guayaquil, Ecuador.
Muñoz-Mawyin K; Laboratorio de Ciencias Ómicas, Universidad Espíritu Santo, Samborondón, Ecuador.
Fernández-Cadena JC; African Genome Center, University Mohammed VI Polytechnic (UM6P), Ben Guerir, Morocco.
García-Moreira E; Instituto Superior Tecnológico Argos, Guayaquil, Ecuador.
Andrade-Molina D; Facultad de Ciencias de la Salud, Universidad Espíritu Santo, Samborondón, Ecuador.; Laboratorio de Ciencias Ómicas, Universidad Espíritu Santo, Samborondón, Ecuador.
Licona-Cassani C; Escuela de Ingeniería y Ciencias, Tecnológico de Monterrey, Monterrey, Nuevo León, México.
Berná L; Laboratorio de Interacciones Hospedero-Patógeno, Unidad de Biología Molecular, Institut Pasteur de Montevideo, Montevideo, Uruguay.; Unidad de Genómica Evolutiva, Facultad de Ciencias, Universidad de la República, Montevideo, Uruguay.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Dec 05; Vol. 18 (12), pp. e0294670. Date of Electronic Publication: 2023 Dec 05 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Ecuador/epidemiology ; Pandemics ; Computational Biology ; Genomics ; Mutation ; Microbial Sensitivity Tests ; Internet ; Drug Resistance, Multiple, Bacterial/genetics
Czasopismo naukowe
Tytuł:
Interactive effect of oral anti-hyperglycaemic or anti-hypertensive drugs on the inhibitory and bactericidal activity of first line anti-TB drugs against M. tuberculosis.
Autorzy:
Trivedi P; Biochemistry and Structural Biology Division, Central Drug Research Institute, Lucknow, UP, India.
Chaturvedi V; Biochemistry and Structural Biology Division, Central Drug Research Institute, Lucknow, UP, India.
Pokaż więcej
Źródło:
PloS one [PLoS One] 2023 Nov 30; Vol. 18 (11), pp. e0292397. Date of Electronic Publication: 2023 Nov 30 (Print Publication: 2023).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis*/drug therapy
Hypertension*/drug therapy
Diabetes Mellitus*/drug therapy
Tuberculosis, Multidrug-Resistant*/drug therapy
Humans ; Antitubercular Agents/pharmacology ; Antitubercular Agents/therapeutic use ; Antihypertensive Agents/pharmacology ; Antihypertensive Agents/therapeutic use ; Ethambutol/therapeutic use ; Pharmaceutical Preparations ; Isoniazid/therapeutic use ; Microbial Sensitivity Tests ; Hypoglycemic Agents/therapeutic use
Czasopismo naukowe
Tytuł:
Advanced drug delivery and therapeutic strategies for tuberculosis treatment.
Autorzy:
Nair A; Department of Pharmaceutics, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
Greeny A; Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
Nandan A; Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
Sah RK; Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
Jose A; Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India.
Dyawanapelly S; Department of Pharmaceutical Sciences and Technology, Institute of Chemical Technology, Mumbai, 400019, India.
Junnuthula V; Drug Research Program, Faculty of Pharmacy, University of Helsinki, Viikinkaari 5 E, 00790, Helsinki, Finland. .
K V A; Department of Pharmacology, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India. .
Sadanandan P; Department of Pharmaceutical Chemistry, Amrita School of Pharmacy, Amrita Vishwa Vidyapeetham, AIMS Health Sciences Campus, Kochi, 682 041, Kerala, India. .
Pokaż więcej
Źródło:
Journal of nanobiotechnology [J Nanobiotechnology] 2023 Nov 09; Vol. 21 (1), pp. 414. Date of Electronic Publication: 2023 Nov 09.
Typ publikacji:
Journal Article; Review
MeSH Terms:
Nanotubes, Carbon*
Tuberculosis*/drug therapy
Mycobacterium tuberculosis*
Humans ; Antitubercular Agents/therapeutic use ; Antitubercular Agents/pharmacology ; Drug Delivery Systems ; Nanomedicine
Czasopismo naukowe
Tytuł:
Free Energy Barriers for Passive Drug Transport through the Mycobacterium tuberculosis Outer Membrane: A Molecular Dynamics Study.
Autorzy:
Steshin IS; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Vasyankin AV; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Shirokova EA; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Rozhkov AV; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Livshits GD; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Panteleev SV; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Radchenko EV; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.; Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, Moscow 119991, Russia.
Ignatov SK; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.
Palyulin VA; Department of Chemistry, Lobachevsky State University of Nizhny Novgorod, Nizhny Novgorod 603022, Russia.; Department of Chemistry, Lomonosov Moscow State University, Leninskie Gory 1/3, Moscow 119991, Russia.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 13; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 13.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis*
Humans ; Molecular Dynamics Simulation ; Prospective Studies ; Cell Wall ; Antitubercular Agents/pharmacology
Czasopismo naukowe
Tytuł:
Structural Insights into the Penicillin-Binding Protein 4 (DacB) from Mycobacterium tuberculosis .
Autorzy:
Kang SM; College of Pharmacy, Duksung Women's University, Seoul 01369, Republic of Korea.
Kim DH; Jeju Research Institute of Pharmaceutical Sciences, College of Pharmacy, Jeju National University, Jeju 63243, Republic of Korea.; Interdisciplinary Graduate Program in Advanced Convergence Technology & Science, Jeju National University, Jeju 63243, Republic of Korea.
Pokaż więcej
Źródło:
International journal of molecular sciences [Int J Mol Sci] 2024 Jan 12; Vol. 25 (2). Date of Electronic Publication: 2024 Jan 12.
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Penicillin-Binding Proteins/genetics ; Antitubercular Agents ; Cell Membrane ; Cell Wall
Czasopismo naukowe
Tytuł:
Rapid detection of drug-resistant Mycobacterium tuberculosis by Modified MODS assay suitable for resource-poor settings.
Autorzy:
Fomda BA; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Bashir G; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Baqal S; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Mir YB; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Ali R; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Khan AH; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Khan A; Department of Microbiology, Sher-i-Kashmir Institute of Medical Sciences, Srinagar, Jammu and Kashmir, India.
Bashir A; All India Institute of Medical Sciences, New Delhi, India.
Chuloo GM; State TB Officer, Directorate of Health Services, Kashmir Province, Srinagar, Jammu and Kashmir, India.
Pokaż więcej
Źródło:
PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2024 Jan 04; Vol. 18 (1), pp. e0011852. Date of Electronic Publication: 2024 Jan 04 (Print Publication: 2024).
Typ publikacji:
Journal Article
MeSH Terms:
Mycobacterium tuberculosis*
Tuberculosis, Multidrug-Resistant*/diagnosis
Tuberculosis, Multidrug-Resistant*/genetics
Humans ; Antitubercular Agents/pharmacology ; Microbial Sensitivity Tests ; Agar/pharmacology ; Mutation ; Genotype
Czasopismo naukowe
Tytuł:
Treatment outcomes of retreated patients with isoniazid/rifampicin resistant pulmonary tuberculosis.
Autorzy:
Zhang L; Clinical Center on Tuberculosis, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9, Beiguan, Tongzhou District, Beijing, 101149, P. R. China.
Han X; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
Ge Q; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
Shu W; Clinical Center on Tuberculosis, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9, Beiguan, Tongzhou District, Beijing, 101149, P. R. China.
Sun Y; Clinical Center on Tuberculosis, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9, Beiguan, Tongzhou District, Beijing, 101149, P. R. China.
Gao J; Clinical Center on Tuberculosis, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9, Beiguan, Tongzhou District, Beijing, 101149, P. R. China.
Xie S; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, P.R. China.
Wang J; Clinical Center on Tuberculosis, Beijing Chest Hospital, Capital Medical University/ Beijing Tuberculosis and Thoracic Tumor Research Institute, No. 9, Beiguan, Tongzhou District, Beijing, 101149, P. R. China. .
Gao W; Department of Tuberculosis, Beijing Chest Hospital, Capital Medical University/Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing, 101149, P.R. China. .
Pokaż więcej
Źródło:
BMC infectious diseases [BMC Infect Dis] 2024 Jan 02; Vol. 24 (1), pp. 7. Date of Electronic Publication: 2024 Jan 02.
Typ publikacji:
Journal Article
MeSH Terms:
Tuberculosis, Multidrug-Resistant*/drug therapy
Tuberculosis, Multidrug-Resistant*/epidemiology
Tuberculosis, Pulmonary*/drug therapy
Mycobacterium tuberculosis*
Humans ; Rifampin/therapeutic use ; Isoniazid/therapeutic use ; Antitubercular Agents/therapeutic use ; Retrospective Studies ; Treatment Outcome
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies